Literature DB >> 15346603

Beyond bankable dollars: establishing a business case for improving health care.

Michael Bailit1, Mary Beth Dyer.   

Abstract

To address widespread deficiencies in the quality of health care, the authors argue that health care organizations need to be able to make a "business case" for improving quality--a compelling rationale for financial investment in quality improvement programs. The authors' framework for such a business case is organized around three broad areas: direct financial considerations, strategic considerations, and internal organizational considerations. Within these categories, they offer a total of 10 specific business case arguments, with examples, for investing in quality improvement.

Mesh:

Year:  2004        PMID: 15346603

Source DB:  PubMed          Journal:  Issue Brief (Commonw Fund)        ISSN: 1558-6847


  4 in total

1.  The Costs of Participating in a Diabetes Quality Improvement Collaborative: Variation Among Five Clinics.

Authors:  Neha A Sathe; Robert S Nocon; Brenna Hughes; Monica E Peek; Marshall H Chin; Elbert S Huang
Journal:  Jt Comm J Qual Patient Saf       Date:  2016-01

2.  A business case for quality improvement in addiction treatment: evidence from the NIATx collaborative.

Authors:  Andrew R Quanbeck; Lynn Madden; Eldon Edmundson; James H Ford; K John McConnell; Dennis McCarty; David H Gustafson
Journal:  J Behav Health Serv Res       Date:  2012-01       Impact factor: 1.505

3.  The business case for provider participation in clinical trials research: an application to the National Cancer Institute's community clinical oncology program.

Authors:  Paula H Song; Kristin L Reiter; Bryan J Weiner; Lori Minasian; Ann Scheck McAlearney
Journal:  Health Care Manage Rev       Date:  2013 Oct-Dec

4.  Identifying and understanding benefits associated with return-on-investment from large-scale healthcare Quality Improvement programmes: an integrative systematic literature review.

Authors:  S'thembile Thusini; Maria Milenova; Noushig Nahabedian; Barbara Grey; Tayana Soukup; Claire Henderson
Journal:  BMC Health Serv Res       Date:  2022-08-24       Impact factor: 2.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.